Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Search Materials

View All Favorites

A library of resources for the prevention,
management, and elimination of TB.

Showing 31 - 15 of 39 Results

Number of items to view
Filter Your Results

Filter Your Results

Title Year
Staying on Track with TB Medicine

This booklet is one of several culturally-appropriate patient education materials produced by the Centers for Disease Control and Prevention and the New Jersey Medical School Global Tuberculosis Institute. All of these patient education materials can be found on the following webpage: www.cdc.gov/tb/pubs/CulturalMaterials...

Persons With LTBI
2005
The PIH Guide to the Medical Management of Multidrug-Resistant Tuberculosis

This pocket guide is intended to be a resource for physicians and other health care professionals who provide care and treatment to patients with MDR TB in DOTS-Plus projects.

2003
Treatment of Tuberculosis. Morbidity and Mortality Weekly Report Recommendations and Reports June 20 2003; 52(RR-11)1-77

This report presents recommendations for the treatment of tuberculosis.

2003
Treatment of Drug-Susceptible Tuberculosis Disease in HIV-Infected Persons

This fact sheet, available online or via fax only, discusses TB treatment options for persons with HIV/AIDS, including dosage recommendations for HIV-infected adults and children. It also discusses adverse reactions and special situations such as extrapulmonary TB, TB in HIV-infected pregnant women, and drug-resistant TB.

Infection Control and Occupational Health Workers
2003
What You Should Know About Taking Tuberculosis Medicines

This pamphlet discusses taking TB medicines, explains directly observed therapy, and the importance of taking all medications for the prescribed period of time.

2002
A DOTS-Plus Handbook: Guide to the Community-Based Treatment of MDR TB

This book describes the technical framework and principles used to implement DOTS-Plus in resource poor settings. It also provides a number of case histories that illustrate common challenges in the treatment of MDR TB patients. The book includes protocols that can be used under DOTS-Plus program conditions to manage common complication of this therapy.

2002
MMWR: Update: Fatal and Severe Liver Injuries Associated With Rifampin and Pyrazinamide for Latent Tuberculosis Infection, and Revisions in American Thoracic Society/CDC Recommendations--United States, 2001

This report provides preliminary information about 21 cases of liver injury associated with rifampin-pyrazinamide (RIF-PZA) and the revised recommendations on selecting appropriate therapy for patients with latent TB infection and monitoring the use of RIF-PZA to treat infection.

2001
MMWR: Fatal and Severe Hepatitis Associated with Rifampin and Pyrazinamide for the Treatment of Latent Tuberculosis Infection--New York and Georgia, 2000

This report discusses two cases of latent TB infection in which patients developed severe or fatal hepatitis associated with rifampin-pyrazinamide (RIF-PZA) treatment.

2001
INH: Standing Between You and Tuberculosis

This pamphlet discusses the use of the drug isoniazid (INH) to treat latent TB infection. It provides information on the length of treatment and side effects.

2001